Detection of human topoisomerase IIα in cell lines and tissues: Characterization of five novel monoclonal antibodies

Journal of Histochemistry and Cytochemistry

Volumn 45, Issue 2, 1997, Pages 251-263

  Kellner, Udo ^a   Heidebrecht, Hans Juergen ^a   Rudolph, Pierre ^a   Biersack, Harald ^b   Buck, Friedrich ^c   Dakowski, Thomas ^a   Wacker, Hans Heinrich ^a   Domanowski, Marcus ^a   Seidel, André ^a   Westergaard, Ole ^b   Parwaresch, Reza ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF HAMBURG   (Germany)

Author keywords

confocal laser microscopy; human topoisomerase II ; immunohistochemistry; monoclonal antibodies; proliferation; Western blot analysis

Indexed keywords

CELL NUCLEUS ANTIGEN; DNA TOPOISOMERASE (ATP HYDROLYSING); EPITOPE; MONOCLONAL ANTIBODY;

ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; BINDING SITE; CELL CYCLE; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CONFOCAL LASER MICROSCOPY; ENZYME ANALYSIS; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS;

EID: 14444287269     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/002215549704500210     Document Type: Article

References (54)

1. Austin CA, Sng JH, Patel S, Fischer LM (1993) Novel HeLa topoisomerase II is the beta isoform: complete coding sequence and homology with other type II topoisomerases. Biochim Biophys Acta 1172:283-291
2. Berger JM, Gamblin SJ, Harrison SC, Wang JC (1996) Structure and mechanism of DNA topoisomerase II. Nature 379:225-232
3. Biersack H, Jensen S, Gromova I, Nielsen IS, Westergaard O, Andersen AH (1996) Active heterodimers are formed from human DNA topoisomerase IIα and IIβ isoforms Proc Natl Acad Sci USA 93:8288-8293
4. Boege F, Andersen A, Jensen S, Zeidler R, Kreipe H (1995) Proliferation-associated nuclear antigen Ki-S1 is identical with topoisomerase II alpha. Delineation of a carboxy-terminal epitope with peptide antibodies. Am J Pathol 146:1302-1308
5. Boege F, Kjeldsen E, Gieseler F, Alsner J, Biersack H (1993) A drug-resistant variant of topoisomerase IIα in human HL-60 cells exhibits alterations in catalytic pH optimum, DNA binding and sub-nuclear distribution. Eur J Biochem 218:575-584
6. Bugg BY, Danks MK, Beck WT, Suttle DP (1991) Expression of a mutant DNA toposomerase in CCRF-CEM human leukemic cells selected for resistance to teniposide. Proc Natl Acad Sci USA 88:7654-7658
7. Camplejohn RS, Brock A, Barnes DM, Gillett C, Raikundalia B, Kreipe H, Parwaresch MR (1993) Ki-S1, a novel proliferative marker: flow cytometric assessment of staining in human breast carcinoma cells. Br J Cancer 67:657-662
8. Capranico G, Tinelli S, Austin CA, Fisher ML, Zunino F (1992) Different patterns of gene expression of topoisomerase II isoforms in differentiated tissues during murine development. Biochim Biophys Acta 1132:43-48
9. Caron PR, Watt P, Wang JC (1994) The C-terminal domain of Saccharomyces cerevisiae DNA topoisomerase II. Mol Cell Biol 14:3197-3207
10. Chen AY, Liu LF (1994) DNA topoisomerases: essential enzymes and lethal targets. Annu Rev Pharmacol Toxicol 34:191-218
11. Chung TDY, Drake FH, Tan KB, Per SR, Crooke ST, Mirabelli CK (1989) Characterization and immunological identification or cDNA clones encoding two human DNA topoisomerase II isozymes. Proc Natl Acad Sci USA 86:9431-9435
12. Cordell JL, Falini B, Erber WN, Ghosh AK, Abdulaziz Z, MacDonald S, Pulford KAF, Stein H, Mason DY (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229
13. Danks MK, Warmoth MR, Friche E, Granzen B, Bugg BY, Harker WG, Zwelling LA, Futscher BW, Suttle DP, Beck WT (1993) Single-strand conformational polymorphism analysis of the M(r) 170,000 isozyme of DNA topoisomerase II in human tumor cells. Cancer Res 53:1373-1379
14. Davies SM, Robson CN, Davies SL, Hickson ID (1988) Nuclear topoisomerase II levels correlate with the sensitivity of mammalian cells to intercalating agents and epipodophyllotoxins. J Biol Chem 263:17724-17729
15. Diehl V, Kirchner HH, Schaadt M, Fonatsch C, Stem H, Gerdes J, Boie C (1981) Hodgkin's disease: establishment and characterization of four in vitro cell lines. J Cancer Res Clin Oncol 101:111-124
16. Dougherty GJ, Hogg N (1987) The role of monocyte lymphocyte function-associated antigen 1 (LFA-1) in accessory cell function. Eur J Immunol 17:943-947
17. Drake FH, Hofmann GA, Bartus HF, Mattern MR, Crooke ST, Mirabelli CK (1989) Biochemical and pharmacological properties of p170 and p180 forms of topoisomerase II. Biochemistry 28:8154-8160
18. Drake FH, Zimmerman JP, McCabe FL, Bartus HF, Per SR, Sullivan DM, Ross WE, Mattern MR, Johnson RK, Crooke ST, Mirabelli CK (1987) Purification of topoisomerase II from amsacrine-resistant P388 leukemia cells. Evidence for two forms of the enzyme. J Biol Chem 262:16739-16747
19. Drolet M, Wu HY, Liu LF (1994) Roles of DNA topoisomerases in transcription. Adv Pharmacol 29:135-146
20. Earnshaw WC, Halligan B, Cooke CA, Heck MM, Liu LF (1985) Topoisomerase II is a structural component of mitotic chromosome scaffolds. J Cell Biol 100:1706-1715
21. Feldhoff PW, Mirski SE, Cole SP, Sullivan DM (1994) Altered subcellular distribution of topoisomerase II alpha in a drug-resistant human small cell lung cancer cell line. Cancer Res 54:756-762
22. Fry AM Chresta CM, Davies SM, Walker MC, Harris AL, Hartley JA, Masters JR, Hickson ID (1991) Relationship between topoisomerase II level and chemosensitivity in human tumor cell lines. Cancer Res 51:6592-6595
23. Gieseler F, Boege F, Biersack H, Spohn B, Clark M, Wilms K (1991) Nuclear topoisomerase II activity changes during HL-60 leukemic cell differentiation: alterations in drug sensitivity and pH dependency. Leukemia Lymphoma 5:273-279
24. Gieseler F, Boege F, Clark M (1990) Alteration of topoisomerase II action is a possible molecular mechanism of HL-60 cell differentiation. Environ Health Persp 88:183-185
25. Heck MMS, Earnshaw WC (1986) Topoisomerase II: a specific-marker for cell proliferation. J Cell Biol 103:2569-2581
26. Holden JA, Snow GW, Perkins SL, Jolies CJ, Kjeldsberg CR (1994) Immunohistochemical staining for DNA topoisomerase II in frozen and formalin-fixed paraffin-embedded human tissues. Mod Pathol 7:829-834
27. Hwang J, Hwong CL (1994) Cellular regulation of mammalian DNA topoisomerases. Adv Pharmacol 29:167-189
28. Ishida R, Sato M, Narita T, Utsumi KR, Nishimoto T, Monta T, Nagata H, Andoh T (1994) Inhibition of DNA topoisomerase II by ICRF-193 induces polyploidization by uncoupling chromosome dynamics from other cell cycle events. J Cell Biol 126: 1341-1351
29. Jenkins JR, Ayton P, Jones T, Davies SL, Simmons DL, Harris AL, Sheer D, Hickson ID (1992) Isolation of cDNA clones encoding the β isozyme of human DNA topoisomerase II and localisation of the gene to chromosome 3p24. Nucleic Acids Res 20:5587-5592
30. Kaufmann SH, McLaughlin SJ, Kastan MB, Liu LF, Karp JE, Burke PJ (1991) Topoisomerase II levels during granulocyte maturation in vitro and in vivo. Cancer Res 51:3534-3543
31. Köhler G, Milstein C (1975) Continuous cultures of fused cells secreting antibody of predefined specificity. Nature 256:495-497
32. Kreipe H, Alm P, Olsson H, Hauberg M, Fischer L, Parwaresch R (1993a) Prognostic significance of a formalin-resistant nuclear proliferation antigen in mammary carcinomas as determined by the monoclonal antibody Ki-S1. Am J Pathol 142:651-657
33. Kreipe H, Heidebrecht HJ, Hansen S, Rohlk W, Kubbies M, Wacker HH, Tiemann M, Radzun HJ, Parwaresch R (1993b) A new proliferation-associated nuclear antigen detectable in paraffin-embedded tissues by the monoclonal antibody Ki-S1. Am J Pathol 142:3-9
34. Kreipe H, Radzun HJ, Rudolph P, Barth J, Hansmann M-L, Heidorn K, Parwaresch MR (1988) Multinucleated giant cells generated in vitro: terminally differentiated macrophages with down-regulated c-fms expression. Am J Pathol 130:232-243
35. 4. Nature 227:680-683
36. Negri C, Scovassi AI, Braghetti A, Guano F, Astaldi Ricotti GC (1993) DNA topoisomerase II beta: stability and distribution in different animal cells in comparison to DNA topoisomerase I and II alpha. Exp Cell Res 206:128-133
37. Nitiss JL (1994) Roles of DNA topoisomerases in chromosomal replication and segregation. Adv Pharmacol 29:103-134
38. Petrov P, Drake FH, Loranger A, Huang W, Hancock R (1993) Localization of DNA topoisomerase II in Chinese hamster fibroblasts by confocal and electron microscopy. Exp Cell Res 204: 73-81
39. Rudolph P, Heidebrecht H-J, Kellner U, Seidel A, Parwaresch MR (1995a) Proliferation marker Ki-S1 binds to a formalin-resistant epitope of topoisomerase II. Int J Surg Pathol 2:388
40. Rudolph P, Lappe T, Schubert C, Schmidt D, Parwaresch RM, Christophers E (1995b) Diagnostic assessment of two novel proliferation-specific antigens in benign and malignant melanocytic lesions. Am J Pathol 147:1615-1625
41. Rudolph P, Parwaresch R (1995) How do cells cycle? Virchows Arch 427:323-325
42. Sampson SA, Kreipe H, Gillett CE, Smith P, Chaudary MA, Khan A, Wicks K, Parwaresch R, Barnes DM (1992) KiS1 - a novel monoclonal antibody which recognizes proliferating cells: evaluation of its relationship to prognosis in mammary carcinoma. J Pathol 168:179-185
43. Sasse J, Gallagher SR (1996) Analysis of proteins. In Ausabel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Struhl K, eds. Current Protocols in Molecular Biology. New York, John Wiley & Sons
44. Shi S-R, Key ME, Kalra KL (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 39:741-748
45. Stein H, Gatter K, Asbahr H, Mason DY (1985) Methods in laboratory investigation. Use of freeze-dried paraffin-embedded sections for immunohistologic staining with monoclonal antibodies. Lab Invest 52:676-683
46. Tan KB, Dorman TE, Falls KM, Chung TDY, Mirabelli CK, Crooke ST, Mao J (1992) Topoisomerase IIα and topoisomerase IIβ genes: characterization and mapping to human chromosomes 17 and 3, respectively. Cancer Res 52:231-234
47. Tsai-Pflugfelder M, Liu LF, Liu AA, Tewey KM, Whang-Peng J, Knutsen T, Huebner K, Croce CM, Wang JC (1988) Cloning and sequencing of cDNA encoding human DNA topoisomerase II and localization of the gene to chromosome region 17q21-22. Proc Natl Acad Sci USA 85:7177-7181
48. Tsutsui K, Okada S, Watanabe M, Shohmon T, Seki S, Inoue Y (1993) Molecular cloning of partial cDNAs for rat DNA topoisomerase II isoforms and their differential expression in brain development. J Biol Chem 268:19076-19083
49. Wang JC (1994) DNA topoisomerases as targets of therapeutics: an overview. Adv Pharmacol 29:1-19
50. Watanabe M, Tsutsui K, Inoue Y (1994) Differential expressions of the topoisomerase II alpha and II beta mRNAs in developing rat brain. Neurosci Res 19:51-57
51. Webb CD, Latham MD, Lock RB, Sullivan DM (1991) Attenuated topoisomerase II content directly correlates with a low level of drug resistance in a Chinese hamster ovary cell line. Cancer Res 51:6543-6549
52. Woessner RD, Mattern MR, Mirabelli CK, Johnson RK, Drake FH (1991) Proliferation- and cell cycle-dependent differences in expression of the 170 kilodalton and 180 kilodalton forms of topoisomerase II in NIH-3T3 cells. Cell Growth Differ 2:209-214
53. Zini N, Martelli AM, Sabatelli P, Santi S, Negri C, Astaldi Ricotti GCB Maraldi NM (1992) The 180-kDa isoform of topoisomerase II is localized in the nucleolus and belongs to the structural elements of the nucleolar remnant. Exp Cell Res 200:460-466
54. Zini N, Santi S, Ognibene A, Bavelloni A, Neri LM, Valmori A, Mariani E, Negri C, Astaldi Ricotti GC, Maraldi NM (1994) Discrete localization of different DNA topoisomerases in HeLa and K562 cell nuclei and subnuclear fractions. Exp Cell Res 210:336-348